Alpha Tau Medical (DRTS) vs Kailera Therapeutics (KLRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Kailera Therapeutics is the larger company by market cap ($1.31 billion vs $1.27 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DRTS | KLRA |
|---|---|---|
| Share price | $13.76 | $10.12 |
| Market cap | $1.27B | $1.31B |
| 1-day change | -3.44% | -3.89% |
| YTD return | +187.88% | — |
| 1-year return | +245.04% | — |
| 5-year return | +44.08% | — |
| EPS (TTM) | $-1.04 | $-4.51 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.79 | $28.23 |
| 52-week low | $3.43 | $9.85 |
| Distance from 52-week high | -12.86% | -64.15% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +29.36% | +318.97% |
| Average volume | 566.95K | 848.03K |
| Shares outstanding | 92.48M | 129.64M |
| Employees | 121 | 145 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Alpha Tau Medical
DRTS stock →Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.
Health Care · Medical/Dental Instruments · 121 employees
About Kailera Therapeutics
KLRA stock →Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 145 employees
DRTS vs KLRA FAQ
Which is bigger, Alpha Tau Medical or Kailera Therapeutics?
Kailera Therapeutics (KLRA) is larger, with a market capitalization of $1.31B compared with $1.27B for Alpha Tau Medical (DRTS).
Are Alpha Tau Medical and Kailera Therapeutics in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Alpha Tau Medical and Biotechnology: Pharmaceutical Preparations for Kailera Therapeutics.